Woodline Partners »

Q32 Bio shares owned by Woodline Partners

Quarter-by-quarter ownership of Q32 Bio (QTTB) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Q32 Bio

Tip: Access up to 7 years of quarterly data

All positions including Q32 Bio held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q32 Bio by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.8M 107k 44.62
2024-03-31 $266k 16k 17.04

More positions owned by Woodline Partners

Meta Platforms Cl A (META)
Gilead Sciences (GILD)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Asml Holding N V N Y Registry Shs (ASML)
Nuvalent Inc-a (NUVL)
Permian Resources Corp Class A Com (PR)
Encana Corporation (OVV)
Keysight Technologies (KEYS)
Danaher Corporation (DHR)
Aon Shs Cl A (AON)
Stmicroelectronics N V Ny Registry (STM)
Regeneron Pharmaceuticals (REGN)
EQT Corporation (EQT)

View all positions for Woodline Partners

Top funds holding Q32 Bio

OrbiMed Advisors
Atlas Venture Life Science Advisors
Carlyle
BlackRock
BlackRock
Arch Venture Corp
Eventide Asset Management
Harvard Management Company
Vanguard Group
Geode Capital Management
Woodline Partners
State Street Corporation
Point72 Asset Management
Platinum Investment Mangement
Ensign Peak Advisors

View all funds holding Q32 Bio